{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T09:13:25Z","timestamp":1788513205890,"version":"build-2803163510"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:00:00Z","timestamp":1788480000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:00:00Z","timestamp":1788480000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Anna Dorothea Hingst Stichting and the Groningen Melanoma Sarcoma Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BJC Rep"],"DOI":"10.1038\/s44276-026-00238-6","type":"journal-article","created":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T08:22:40Z","timestamp":1788510160000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Mucosal melanoma in 1481 patients in the Netherlands. An overview of metastatic patterns, main driver mutations and the efficacy of therapeutic strategies"],"prefix":"10.1038","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1511-2027","authenticated-orcid":false,"given":"E.","family":"Jutten","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Kruijff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. H. M.","family":"Oonk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. F.","family":"Lutke Holzik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. L.","family":"van Leeuwen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. P.","family":"Wevers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,4]]},"reference":[{"key":"238_CR1","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/978-3-319-22539-5_13","volume":"167","author":"KR Spencer","year":"2016","unstructured":"Spencer KR, Mehnert JM. Mucosal melanoma: epidemiology, biology and treatment. Cancer Treat Res. 2016;167:295\u2013320.","journal-title":"Cancer Treat Res"},{"key":"238_CR2","doi-asserted-by":"publisher","first-page":"MMT11","DOI":"10.2217\/mmt-2018-0003","volume":"5","author":"H Tyrrell","year":"2018","unstructured":"Tyrrell H, Payne M. Combatting mucosal melanoma: recent advances and future perspectives. Melanoma Manag. 2018;5:MMT11.","journal-title":"Melanoma Manag"},{"key":"238_CR3","first-page":"739","volume":"5","author":"M Mihajlovic","year":"2012","unstructured":"Mihajlovic M, Vlajkovic S, Jovanovic P, Stefanovic V. Primary mucosal melanomas: a comprehensive review. Int J Clin Exp Pathol. 2012;5:739\u201353.","journal-title":"Int J Clin Exp Pathol"},{"key":"238_CR4","doi-asserted-by":"publisher","first-page":"702287","DOI":"10.3389\/fonc.2021.702287","volume":"11","author":"Y Ma","year":"2021","unstructured":"Ma Y, Ma Y, Xia R, Ma X, Judson-Torres RL, Judson-Torres RL, et al. Mucosal melanoma: pathological evolution, pathway dependency and targeted therapy. Front Oncol. 2021;11:702287.","journal-title":"Front Oncol"},{"key":"238_CR5","first-page":"116","volume":"11","author":"HM Hahn","year":"2019","unstructured":"Hahn HM, Lee KG, Choi W, Cheong SH, Myung KB, Hahn HJ. An updated review of mucosal melanoma: Survival meta-analysis. Mol Clin Oncol. 2019;11:116\u201326.","journal-title":"Mol Clin Oncol"},{"key":"238_CR6","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.semcancer.2019.09.013","volume":"61","author":"KW Nassar","year":"2020","unstructured":"Nassar KW, Tan AC. The mutational landscape of mucosal melanoma. Semin Cancer Biol. 2020;61:139\u201348.","journal-title":"Semin Cancer Biol"},{"key":"238_CR7","first-page":"19","volume":"29","author":"M Casparie","year":"2007","unstructured":"Casparie M, Tiebosch AT, Burger G, Blauwgeers H, van de Pol A, van Krieken JH, et al. Pathology databanking and biobanking in The Netherlands, a central role for PALGA, the nationwide histopathology and cytopathology data network and archive. Cell Oncol. 2007;29:19\u201324.","journal-title":"Cell Oncol"},{"key":"238_CR8","unstructured":"Netherlands Cancer Registry (NCR), hosted by the Netherlands Comprehensive Cancer Organization (IKNL). Retrieved dataset mucosaal melanoom. (2021) (08)."},{"key":"238_CR9","unstructured":"Amin MB, Edge SB, Greene FL, Byrd DR, Brookland RK, Washington MK, et al. AJCC Cancer Staging Manual. 8th ed.: Springer Cham; (2016)."},{"key":"238_CR10","doi-asserted-by":"crossref","unstructured":"Cui C, Lian B, Guo J. An evidence-based staging system for mucosal melanoma: a proposal. (2022).","DOI":"10.1245\/s10434-022-11670-6"},{"key":"238_CR11","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1097\/CMR.0000000000000628","volume":"30","author":"LD Guti\u00e9rrez-Casta\u00f1eda","year":"2020","unstructured":"Guti\u00e9rrez-Casta\u00f1eda LD, Nova JA, Tovar-Parra JD. Frequency of mutations in BRAF, NRAS, and KIT in different populations and histological subtypes of melanoma: a systemic review. Melanoma Res. 2020;30:62\u201370.","journal-title":"Melanoma Res"},{"key":"238_CR12","first-page":"2320","volume":"10","author":"C Teixido","year":"2021","unstructured":"Teixido C, Castillo P, Martinez-Vila C, Arance A, Alos L. Molecular Markers and Targets in Melanoma. Cells (Basel, Switz). 2021;10:2320.","journal-title":"Cells (Basel, Switz)"},{"key":"238_CR13","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.ejca.2017.05.014","volume":"81","author":"MV Heppt","year":"2017","unstructured":"Heppt MV, Roesch A, Weide B, Gutzmer R, Meier F, Loquai C, et al. Prognostic factors and treatment outcomes in 444 patients with mucosal melanoma. Eur J Cancer. 2017;81:36\u201344.","journal-title":"Eur J Cancer"},{"key":"238_CR14","doi-asserted-by":"publisher","first-page":"e5753","DOI":"10.1097\/MD.0000000000005753","volume":"96","author":"T Schaefer","year":"2017","unstructured":"Schaefer T, Satzger I, Gutzmer R. Clinics, prognosis and new therapeutic options in patients with mucosal melanoma: a retrospective analysis of 75 patients. Med (Baltim). 2017;96:e5753.","journal-title":"Med (Baltim)"},{"key":"238_CR15","doi-asserted-by":"publisher","first-page":"3977","DOI":"10.2217\/fon-2019-0465","volume":"15","author":"A Al-Haseni","year":"2019","unstructured":"Al-Haseni A, Vrable A, Qureshi MM, Mathews S, Pollock S, Truong M, et al. Survival outcomes of mucosal melanoma in the USA. Future Oncol. 2019;15:3977\u201386.","journal-title":"Future Oncol"},{"key":"238_CR16","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1093\/annonc\/mdw694","volume":"28","author":"B Lian","year":"2017","unstructured":"Lian B, Cui CL, Zhou L, Song X, Zhang XS, Wu D, et al. The natural history and patterns of metastases from mucosal melanoma: an analysis of 706 prospectively-followed patients. Ann Oncol. 2017;28:868\u201373.","journal-title":"Ann Oncol"},{"key":"238_CR17","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.3390\/cancers15051356","volume":"15","author":"DA Santeufemia","year":"2023","unstructured":"Santeufemia DA, Palmieri G, Miolo G, Colombino M, Doro MG, Frogheri L, et al. Current trends in mucosal melanomas: an overview. Cancers. 2023;15:1356.","journal-title":"Cancers"},{"key":"238_CR18","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1634\/theoncologist.2015-0522","volume":"21","author":"D Kuk","year":"2016","unstructured":"Kuk D, Shoushtari AN, Barker CA, Panageas KS, Munhoz RR, Momtaz P, et al. Prognosis of mucosal, uveal, acral, nonacral cutaneous, and unknown primary melanoma from the time of first metastasis. Oncologist (Dayt, Ohio). 2016;21:848\u201354.","journal-title":"Oncologist (Dayt, Ohio)"},{"key":"238_CR19","doi-asserted-by":"publisher","DOI":"10.1177\/1758835920922028","volume":"12","author":"J Li","year":"2020","unstructured":"Li J, Kan H, Zhao L, Sun Z, Bai C. Immune checkpoint inhibitors in advanced or metastatic mucosal melanoma: a systematic review. Ther Adv Med Oncol. 2020;12:1758835920922028.","journal-title":"Ther Adv Med Oncol"},{"key":"238_CR20","doi-asserted-by":"crossref","unstructured":"Blank CU, Lucas MW, Scolyer RA, van de Wiel BA, Menzies AM, Lopez-Yurda M, et al. Neoadjuvant Nivolumab and Ipilimumab in Resectable Stage III Melanoma. New Engl J Med 2024;391:1696\u2013708.","DOI":"10.1056\/NEJMoa2402604"},{"key":"238_CR21","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1056\/NEJMoa2211437","volume":"388","author":"SP Patel","year":"2023","unstructured":"Patel SP, Othus M, Chen Y, Wright GP, Yost KJ, Hyngstrom JR, et al. Neoadjuvant\u2013Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma. N Engl J Med. 2023;388:813\u201323.","journal-title":"N Engl J Med"},{"key":"238_CR22","doi-asserted-by":"publisher","first-page":"4373","DOI":"10.1016\/j.cell.2024.06.036","volume":"187","author":"AR Cillo","year":"2024","unstructured":"Cillo AR, Cardello C, Shan F, Karapetyan L, Kunning S, Sander C, et al. Blockade of LAG-3 and PD-1 leads to co-expression of cytotoxic and exhaustion gene modules in CD8+ T cells to promote antitumor immunity. Cell. 2024;187:4373\u201388.e15.","journal-title":"Cell"},{"key":"238_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1349081","volume":"14","author":"J Su","year":"2024","unstructured":"Su J, Fu Y, Cui Z, Abidin Z, Yuan J, Zhang X, et al. Relatlimab: a novel drug targeting immune checkpoint LAG-3 in melanoma therapy. Front Pharmacol. 2024;14:1349081.","journal-title":"Front Pharmacol"},{"key":"238_CR24","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1056\/NEJMoa2109970","volume":"386","author":"HA Tawbi","year":"2022","unstructured":"Tawbi HA, Schadendorf D, Lipson EJ, Ascierto PA, Matamala L, Castillo Guti\u00e9rrez E, et al. Relatlimab and nivolumab versus nivolumab in untreated advanced melanoma. N Engl J Med. 2022;386:24\u201334.","journal-title":"N Engl J Med"},{"key":"238_CR25","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.cps.2021.05.010","volume":"48","author":"D Olla","year":"2021","unstructured":"Olla D, Neumeister MW. Mucosal melanoma. Clin Plast Surg. 2021;48:707\u201311.","journal-title":"Clin Plast Surg"},{"key":"238_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-57253-6","volume":"10","author":"D Cohen Goldemberg","year":"2020","unstructured":"Cohen Goldemberg D, de Melo AC, de Melo Pino LC, Thuler LCS. Epidemiological profile of mucosal melanoma in Brazil. Sci Rep. 2020;10:505.","journal-title":"Sci Rep"},{"key":"238_CR27","doi-asserted-by":"publisher","first-page":"4747","DOI":"10.1002\/cncr.26088","volume":"117","author":"P Kelly","year":"2011","unstructured":"Kelly P, Zagars GK, Cormier JN, Ross MI, Guadagnolo BA. Sphincter-sparing local excision and hypofractionated radiation therapy for anorectal melanoma. Cancer. 2011;117:4747\u201355.","journal-title":"Cancer"},{"key":"238_CR28","doi-asserted-by":"publisher","first-page":"e112535","DOI":"10.1371\/journal.pone.0112535","volume":"9","author":"T Mehra","year":"2014","unstructured":"Mehra T, Gr\u00f6zinger G, Mann S, Guenova E, Moos R, R\u00f6cken M, et al. Primary localization and tumor thickness as prognostic factors of survival in patients with mucosal melanoma. PLoS One. 2014;9:e112535.","journal-title":"PLoS One"},{"key":"238_CR29","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.jaad.2018.09.054","volume":"81","author":"L Altieri","year":"2019","unstructured":"Altieri L, Eguchi M, Peng DH, Cockburn M. Predictors of mucosal melanoma survival in a population-based setting. J Am Acad Dermatol. 2019;81:136\u201342.e2.","journal-title":"J Am Acad Dermatol"},{"key":"238_CR30","doi-asserted-by":"publisher","first-page":"62","DOI":"10.4065\/74.1.62","volume":"74","author":"D Ost","year":"1999","unstructured":"Ost D, Joseph C, Sogoloff H, Menezes G. Primary pulmonary melanoma: case report and literature review. Mayo Clin Proc. 1999;74:62\u20136.","journal-title":"Mayo Clin Proc"},{"key":"238_CR31","doi-asserted-by":"publisher","first-page":"2244","DOI":"10.1038\/s41379-020-0594-0","volume":"33","author":"C Yang","year":"2020","unstructured":"Yang C, Sanchez-Vega F, Chang JC, Chatila WK, Shoushtari AN, Ladanyi M, et al. Lung-only melanoma: UV mutational signature supports origin from occult cutaneous primaries and argues against the concept of primary pulmonary melanoma. Mod Pathol. 2020;33:2244\u201355.","journal-title":"Mod Pathol"},{"key":"238_CR32","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1136\/thx.35.2.158","volume":"35","author":"AJ Robertson","year":"1980","unstructured":"Robertson AJ, Sinclair DJ, Sutton PP, Guthrie W. Primary melanocarcinoma of the lower respiratory tract. Thorax. 1980;35:158\u20139.","journal-title":"Thorax"},{"key":"238_CR33","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1097\/JTO.0000000000000663","volume":"10","author":"WD Travis","year":"2015","unstructured":"Travis WD, Brambilla E, Burke AP, Marx A, Nicholson AG. Introduction to the 2015 World Health Organization classification of tumors of the lung, pleura, thymus, and heart. J Thorac Oncol. 2015;10:1240\u20132.","journal-title":"J Thorac Oncol"}],"container-title":["BJC Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s44276-026-00238-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44276-026-00238-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44276-026-00238-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T08:22:43Z","timestamp":1788510163000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s44276-026-00238-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,4]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["238"],"URL":"https:\/\/doi.org\/10.1038\/s44276-026-00238-6","relation":{},"ISSN":["2731-9377"],"issn-type":[{"value":"2731-9377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,4]]},"assertion":[{"value":"4 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"44"}}